BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 38389843)

  • 1. Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside.
    Van Laere C; Koole M; Deroose CM; de Voorde MV; Baete K; Cocolios TE; Duchemin C; Ooms M; Cleeren F
    Theranostics; 2024; 14(4):1720-1743. PubMed ID: 38389843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
    Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
    Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
    Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R
    J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
    Nelson BJB; Andersson JD; Wuest F
    Nucl Med Biol; 2022; 110-111():59-66. PubMed ID: 35487834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.
    Ioannidis I; Lefkaritis G; Georgiades SN; Pashalidis I; Kontoghiorghes GJ
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Evaluation of [
    Wharton L; McNeil SW; Merkens H; Yuan Z; Van de Voorde M; Engudar G; Ingham A; Koniar H; Rodríguez-Rodríguez C; Radchenko V; Ooms M; Kunz P; Bénard F; Schaffer P; Yang H
    Molecules; 2023 Apr; 28(7):. PubMed ID: 37049918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge rare earth radiometals: prospects for cancer theranostics.
    Sadler AWE; Hogan L; Fraser B; Rendina LM
    EJNMMI Radiopharm Chem; 2022 Aug; 7(1):21. PubMed ID: 36018527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostics: The Role of Quantitative Nuclear Medicine Imaging.
    Könik A; O'Donoghue JA; Wahl RL; Graham MM; Van den Abbeele AD
    Semin Radiat Oncol; 2021 Jan; 31(1):28-36. PubMed ID: 33246633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutron-activated theranostic radionuclides for nuclear medicine.
    Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
    Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides.
    Morgan KA; Rudd SE; Noor A; Donnelly PS
    Chem Rev; 2023 Oct; 123(20):12004-12035. PubMed ID: 37796539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer.
    Herrero Álvarez N; Bauer D; Hernández-Gil J; Lewis JS
    ChemMedChem; 2021 Oct; 16(19):2909-2941. PubMed ID: 33792195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unconventional nuclides for radiopharmaceuticals.
    Holland JP; Williamson MJ; Lewis JS
    Mol Imaging; 2010 Feb; 9(1):1-20. PubMed ID: 20128994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operational nuclear research reactors in the Asia-Pacific with potential for medical radionuclide production.
    Tan HY; Wong YH; Kasbollah A; Md Shah MN; Perkins AC; Yeong CH
    Nucl Med Commun; 2023 Apr; 44(4):227-243. PubMed ID: 36808108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAMAM Dendrimer-Based Nanodevices for Nuclear Medicine Applications.
    Xiao T; Li D; Shi X; Shen M
    Macromol Biosci; 2020 Feb; 20(2):e1900282. PubMed ID: 31829523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross section measurement of terbium radioisotopes for an optimized
    Dellepiane G; Casolaro P; Favaretto C; Grundler PV; Mateu I; Scampoli P; Talip Z; van der Meulen NP; Braccini S
    Appl Radiat Isot; 2022 Jun; 184():110175. PubMed ID: 35344829
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging.
    Favaretto C; Talip Z; Borgna F; Grundler PV; Dellepiane G; Sommerhalder A; Zhang H; Schibli R; Braccini S; Müller C; van der Meulen NP
    EJNMMI Radiopharm Chem; 2021 Nov; 6(1):37. PubMed ID: 34778932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oncological theranostics in nuclear medicine].
    Laschinsky C; Herrmann K; Fendler W; Nader M; Lahner H; Hadaschik B; Sandach P
    Radiologie (Heidelb); 2022 Oct; 62(10):875-884. PubMed ID: 36112174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals.
    Notni J; Wester HJ
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):141-153. PubMed ID: 29143368
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
    Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.
    Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F
    Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.